We’re pleased to welcome Dr. John Mikhael, MD, PhD, to the LongeVC advisory board.
A computational neuroscientist and medtech founder, Dr. Mikhael works at the intersection of neuroscience, medicine, and AI. His research explores how the brain’s dopamine system drives learning and decision-making—mechanisms central to understanding and diagnosing neurological and psychiatric disorders.
At LongeVC, we’re focused on identifying and supporting technologies with the potential to radically transform healthspan and longevity. Dr. Mikhael’s cross-disciplinary expertise in computational neuroscience and early-stage diagnostics will be invaluable as we evaluate and guide the next wave of health innovation.
You can check Dr. Mikhael’s full bio here.
A computational neuroscientist and medtech founder, Dr. Mikhael works at the intersection of neuroscience, medicine, and AI. His research explores how the brain’s dopamine system drives learning and decision-making—mechanisms central to understanding and diagnosing neurological and psychiatric disorders.
At LongeVC, we’re focused on identifying and supporting technologies with the potential to radically transform healthspan and longevity. Dr. Mikhael’s cross-disciplinary expertise in computational neuroscience and early-stage diagnostics will be invaluable as we evaluate and guide the next wave of health innovation.
You can check Dr. Mikhael’s full bio here.